Logo image of CLNE

CLEAN ENERGY FUELS CORP (CLNE) Stock Fundamental Analysis

NASDAQ:CLNE - Nasdaq - US1844991018 - Common Stock - Currency: USD

1.42  +0.08 (+5.97%)

After market: 1.43 +0.01 (+0.7%)

Fundamental Rating

3

CLNE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 212 industry peers in the Oil, Gas & Consumable Fuels industry. CLNE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CLNE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CLNE was profitable.
In the past year CLNE had a positive cash flow from operations.
In the past 5 years CLNE always reported negative net income.
Each year in the past 5 years CLNE had a positive operating cash flow.
CLNE Yearly Net Income VS EBIT VS OCF VS FCFCLNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

CLNE has a Return On Assets of -6.68%. This is amonst the worse of the industry: CLNE underperforms 82.08% of its industry peers.
CLNE's Return On Equity of -11.65% is on the low side compared to the rest of the industry. CLNE is outperformed by 76.89% of its industry peers.
Industry RankSector Rank
ROA -6.68%
ROE -11.65%
ROIC N/A
ROA(3y)-6.67%
ROA(5y)-6.22%
ROE(3y)-11.16%
ROE(5y)-9.58%
ROIC(3y)N/A
ROIC(5y)N/A
CLNE Yearly ROA, ROE, ROICCLNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

CLNE has a Gross Margin of 30.86%. This is comparable to the rest of the industry: CLNE outperforms 40.09% of its industry peers.
In the last couple of years the Gross Margin of CLNE has declined.
The Profit Margin and Operating Margin are not available for CLNE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.4%
GM growth 5Y-4.26%
CLNE Yearly Profit, Operating, Gross MarginsCLNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

4

2. Health

2.1 Basic Checks

CLNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CLNE has about the same amount of shares outstanding.
The number of shares outstanding for CLNE has been increased compared to 5 years ago.
CLNE has a worse debt/assets ratio than last year.
CLNE Yearly Shares OutstandingCLNE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CLNE Yearly Total Debt VS Total AssetsCLNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

CLNE has an Altman-Z score of -0.29. This is a bad value and indicates that CLNE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.29, CLNE is doing worse than 70.75% of the companies in the same industry.
A Debt/Equity ratio of 0.37 indicates that CLNE is not too dependend on debt financing.
CLNE has a Debt to Equity ratio (0.37) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z -0.29
ROIC/WACCN/A
WACC11.61%
CLNE Yearly LT Debt VS Equity VS FCFCLNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.67 indicates that CLNE has no problem at all paying its short term obligations.
CLNE has a better Current ratio (2.67) than 81.13% of its industry peers.
A Quick Ratio of 2.39 indicates that CLNE has no problem at all paying its short term obligations.
The Quick ratio of CLNE (2.39) is better than 80.19% of its industry peers.
Industry RankSector Rank
Current Ratio 2.67
Quick Ratio 2.39
CLNE Yearly Current Assets VS Current LiabilitesCLNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 166.67% over the past year.
CLNE shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -21.00% yearly.
CLNE shows a decrease in Revenue. In the last year, the revenue decreased by -2.19%.
Measured over the past years, CLNE shows a small growth in Revenue. The Revenue has been growing by 3.86% on average per year.
EPS 1Y (TTM)166.67%
EPS 3Y58.74%
EPS 5Y-21%
EPS Q2Q%100%
Revenue 1Y (TTM)-2.19%
Revenue growth 3Y17.62%
Revenue growth 5Y3.86%
Sales Q2Q%2.31%

3.2 Future

The Earnings Per Share is expected to grow by 65.71% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 22.39% on average over the next years. This is a very strong growth
EPS Next Y-1156.06%
EPS Next 2Y-174.32%
EPS Next 3Y-74.66%
EPS Next 5Y65.71%
Revenue Next Year-0.39%
Revenue Next 2Y6.13%
Revenue Next 3Y1.54%
Revenue Next 5Y22.39%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLNE Yearly Revenue VS EstimatesCLNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
CLNE Yearly EPS VS EstimatesCLNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -0.5 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 35.50, the valuation of CLNE can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of CLNE indicates a slightly more expensive valuation: CLNE is more expensive than 65.09% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.33, CLNE is valued a bit more expensive.
CLNE is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 35.5
Fwd PE N/A
CLNE Price Earnings VS Forward Price EarningsCLNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLNE indicates a slightly more expensive valuation: CLNE is more expensive than 65.57% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.38
CLNE Per share dataCLNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

CLNE's earnings are expected to decrease with -74.66% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-174.32%
EPS Next 3Y-74.66%

More info and screens

0

5. Dividend

5.1 Amount

CLNE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEAN ENERGY FUELS CORP

NASDAQ:CLNE (4/22/2025, 8:00:00 PM)

After market: 1.43 +0.01 (+0.7%)

1.42

+0.08 (+5.97%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-24 2025-02-24/amc
Earnings (Next)05-08 2025-05-08/amc
Inst Owners51.01%
Inst Owner Change-0.18%
Ins Owners0.86%
Ins Owner Change0.88%
Market Cap318.02M
Analysts84
Price Target6.84 (381.69%)
Short Float %5.97%
Short Ratio3.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)184.91%
Min EPS beat(2)184.05%
Max EPS beat(2)185.77%
EPS beat(4)4
Avg EPS beat(4)143.95%
Min EPS beat(4)77.37%
Max EPS beat(4)185.77%
EPS beat(8)7
Avg EPS beat(8)132.68%
EPS beat(12)10
Avg EPS beat(12)85.21%
EPS beat(16)11
Avg EPS beat(16)94.7%
Revenue beat(2)2
Avg Revenue beat(2)3.33%
Min Revenue beat(2)2.21%
Max Revenue beat(2)4.45%
Revenue beat(4)3
Avg Revenue beat(4)-0.29%
Min Revenue beat(4)-9.94%
Max Revenue beat(4)4.45%
Revenue beat(8)4
Avg Revenue beat(8)0.91%
Revenue beat(12)5
Avg Revenue beat(12)-1.58%
Revenue beat(16)7
Avg Revenue beat(16)-7.49%
PT rev (1m)0%
PT rev (3m)-3.83%
EPS NQ rev (1m)-6.52%
EPS NQ rev (3m)-298.61%
EPS NY rev (1m)-408.58%
EPS NY rev (3m)-321.17%
Revenue NQ rev (1m)-2.97%
Revenue NQ rev (3m)-4.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.41%
Valuation
Industry RankSector Rank
PE 35.5
Fwd PE N/A
P/S 0.76
P/FCF N/A
P/OCF 4.92
P/B 0.45
P/tB 0.49
EV/EBITDA 13.38
EPS(TTM)0.04
EY2.82%
EPS(NY)-0.42
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.29
OCFY20.31%
SpS1.86
BVpS3.18
TBVpS2.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.68%
ROE -11.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.86%
FCFM N/A
ROA(3y)-6.67%
ROA(5y)-6.22%
ROE(3y)-11.16%
ROE(5y)-9.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.4%
GM growth 5Y-4.26%
F-Score4
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Debt/EBITDA 16.2
Cap/Depr 178.73%
Cap/Sales 19.23%
Interest Coverage N/A
Cash Conversion 391.72%
Profit Quality N/A
Current Ratio 2.67
Quick Ratio 2.39
Altman-Z -0.29
F-Score4
WACC11.61%
ROIC/WACCN/A
Cap/Depr(3y)180.71%
Cap/Depr(5y)126.79%
Cap/Sales(3y)20.16%
Cap/Sales(5y)15.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)166.67%
EPS 3Y58.74%
EPS 5Y-21%
EPS Q2Q%100%
EPS Next Y-1156.06%
EPS Next 2Y-174.32%
EPS Next 3Y-74.66%
EPS Next 5Y65.71%
Revenue 1Y (TTM)-2.19%
Revenue growth 3Y17.62%
Revenue growth 5Y3.86%
Sales Q2Q%2.31%
Revenue Next Year-0.39%
Revenue Next 2Y6.13%
Revenue Next 3Y1.54%
Revenue Next 5Y22.39%
EBIT growth 1Y63.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year258.77%
EBIT Next 3Y85.78%
EBIT Next 5Y50.31%
FCF growth 1Y80.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.52%
OCF growth 3Y16.07%
OCF growth 5Y39.37%